Welcome to the 13th Cancer Crosslinks: Driving the translation of scientific insights into clinical practice: from “nice to know” to “need to implement”
Cancer Crosslinks will be presented digitally on January 21, 2021. Confirmed speakers include Prof. Ahmad Awada, Jules Bordet Institute, Belgium; Prof. Jérôme Galon, INSERM, France; Prof. Marcela Maus, Harvard Medical School and Massachusetts General Hospital, USA; Prof. Andrew Sewell, Cardiff University, UK and Prof. Emile Voest, Netherlands Cancer Institute.
Please visit www.cancercrosslinks.com to register for this digital event and to view the updated programme.
The goal of the Cancer Crosslinks meetings is to promote interactions between researchers and clinicians, as well as to encourage translational and clinical research, and new collaborations to advance the development of innovative cancer treatments. Cancer Crosslinks Norway has become one of the leading national meeting places gathering oncologists, hematologists, translational researchers, healthcare providers, regulatory experts and industry representatives.
The hallmark of Cancer Crosslinks is the educational program featuring distinguished international and national experts presenting recent advances in oncology. This main program is complemented by tailored activities to stimulate additional interactions and discussions between the Cancer Crosslinks speakers and representatives from the Norwegian Oncology Community.
Contact Jutta Heix, Head of International Affairs, Oslo Cancer Cluster, if you have any further questions.
Cancer Crosslinks 2021 is supported by Bristol Myers Squibb and Merck.